Jump Financial, LLC Aldeyra Therapeutics, Inc. Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Oct 21, 2024	BUY	$5.77 - $9.93 $143,690 - $247,286	24,903 New	24,903 $247,000
Q1 2023 May 03, 2023	BUY	$5.77 - $9.93 $54,220 - $93,312	9,397 Added 60.6%	24,903 $247,000
Q4 2022 Feb 13, 2023	SELL	$5.08 - $7.09 $175,229 - $244,562	-34,494 Reduced 68.99%	15,506 $107,000
Q3 2022 Nov 07, 2022	BUY	$3.8 - $7.74 $190,000 - $387,000	50,000 New	50,000 $267,000
Q3 2021 Nov 12, 2021	SELL	$7.94 - $11.31 $549,567 - $782,821	-69,215 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$10.44 - $14.85 $722,604 - $1.03 Million	69,215 New	69,215 $784,000
Q1 2021 May 17, 2021	SELL	$6.53 - $14.42 $129,947 - $286,958	-19,900 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$6.31 - $8.13 $125,568 - $161,787	19,900 New	19,900 $137,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $278M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.